Navigation Links
Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
Date:9/18/2007

/p>

COPD is a preventable and treatable lung disease characterized by chronic airflow limitation that is not fully reversible.(5) COPD is a leading cause of death, illness, and disability in the United States, with an estimated 10 million to 24 million adults in the US living with COPD.(6)

About Aclidinium Bromide

Aclidinium bromide is a novel inhaled anticholinergic bronchodilator that is currently in phase III clinical development as a once-daily maintenance treatment for COPD.

About Forest Laboratories and Its Products

Forest Laboratories (http://www.frx.com) is a US-based pharmaceutical company dedicated to identifying, developing and delivering products that make a positive difference in peoples' lives. Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment of major depressive disorder and generalized anxiety disorder; Namenda(R) (memantine HCl), an N-methyl D- aspartate (NMDA)-receptor antagonist indicated for the treatment of moderate to severe Alzheimer's disease; Benicar(R)* (olmesartan medoxomil), an angiotensin receptor blocker, and Benicar* HCT(R) (olmesartan medoxomil - hydrochlorothiazide), an angiotensin receptor blocker and diuretic combination product, each indicated for the treatment of hypertension; and Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation.

*Benicar is a registered trademark of Daiichi Sankyo, Inc., and Campral is a registered trademark of Merck Sante s.a.s., subsidiary of Merck KGaA, Darmstadt, Germany.

Except for the historical information contained herein, this release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These sta
'/>"/>

SOURCE Forest Laboratories
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... HOUSTON, TX , Feb. 27, 2015 ... EPI) and Bloom Burton & Co. Ltd. ("Bloom Burton") ... lock-up (the "Lock-Up") 2,353,130 common shares of the Company ... subject to the Lock-Up. Of the Common Shares released ... immediately upon release from the Lock-Up while the remainder ...
(Date:2/27/2015)... February 27, 2015 Report Details ... showing you trends, R&D progress, and predicted revenues ,Where ... What are the commercial prospects for this market and ... revenues and other trends to 2025, discussing data, opportunities ... you assess regenerative medicine : cell-based therapies that ...
(Date:2/27/2015)... , Feb. 27, 2015 /CNW/ - Covalon Technologies Ltd. ... technologies company, today announced financial results for its first ... the three months ended December 31, 2014, revenue was ... quarter was $229,820 or $0.02 per share.  ... said "I am very pleased with the significant progress ...
Breaking Medicine Technology:ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3
... India, July 5th, 2007 – Several data,presentations ... be presented at ,International Brain Research ... be held at Melbourne, Australia during,July 12-17, ... will be presenting new,data for 4 promising ...
... STANFORD, Calif.--(BUSINESS WIRE)--Jul 5, 2007 - Scientists' hunt,for ... suspects and,found so many treatments with different mechanisms ... the Stanford,University School of Medicine have identified one ... causes and treatments,for depression converge., They found that ...
Cached Medicine Technology:Suven Life Sciences Presenting Pre-clinical data of their,NCE’s SUVN-502 and SUVN-507at International Brain Research,Organization (IBRO) 2007 World Congress of Neuroscience 2Stanford Researchers Find Brain Pathway of Depression in Rats 2Stanford Researchers Find Brain Pathway of Depression in Rats 3Stanford Researchers Find Brain Pathway of Depression in Rats 4
(Date:2/27/2015)... 27, 2015 In New York City, ... by providing free dental care from his Sheepshead Bay­neighborhood ... with Dentistry from the Heart, and will be hosting ... first 50 patients who are in need of fillings, ... will have access to high­quality service of Dr. Umanoff's ...
(Date:2/27/2015)... Royal River Natural Foods, a locally-owned independent natural health store ... who got the most magnesium were less than half as ... got the least magnesium, with the largest benefit in those ... of the March 2015 issue of “ Natural Insights for ... each month for the Freeport community to learn more about ...
(Date:2/27/2015)... Legislation passed today by the ... provision to help prevent inappropriate prescriptions in Medicare ... Protecting the Integrity of Medicare Act (PIMA), introduced ... Brady (R-TX) and Ranking Member Jim McDermott (D-WA), ... abuse epidemic and implement the right policies, said ...
(Date:2/27/2015)... The Dawn Greene Hospice, a 10-bed facility located on the ... Upper East Side, was officially dedicated and blessed at a ... Michael Cardinal Dolan. , Thomas J. Fahey, Jr., MD, chairman ... of the ArchCare Board of Trustees, presided over the event ... of MMW, and Christina McInerney, president and CEO of The ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Mediaplanet today ... “Blood Health,” a campaign that aims to bring blood ... health care conversation. The stories in this edition go ... world of clinical care, hard-hitting advocacy, research and technological ... , According the American Cancer Society, approximately every ...
Breaking Medicine News(10 mins):Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 3Health News:New Study Finds Magnesium May Slow Progress of Diabetes, Retailer Reports 2Health News:PCMA Statement on the ‘Protecting the Integrity of Medicare Act’ 2Health News:The Dawn Greene Hospice Is Officially Dedicated 2Health News:The Dawn Greene Hospice Is Officially Dedicated 3Health News:Know Your Blood: Raising Awareness through Mediaplanet’s “Blood Health” Campaign 2
... , , , LOS ANGELES ... $100,000 to the American Red Cross of Greater Los Angeles in ... to feed and shelter 250,000 people following a major disaster, such ... Walt Disney Company,s donation aided the Red Cross in qualifying for ...
... , , , ... Employment Opportunity Commission (EEOC) ruled that Belmont Abbey College, a ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO ) , ... Catholic doctrine and also violates North Carolina state law which ...
... higher level of post-treatment pain appear to have a lower ... pain, according to a report in the August issue of ... the JAMA/Archives journals. "Pain is an important but ... play a predictive role in recurrence and survivorship outcomes," according ...
... , , , ... HTWR ) (ASX: HIN) announced today the completion of ... in a private placement in the United States and Australia (the ... purchase price of US$22.00 per share resulting in gross proceeds of ...
... of historical records points to an epidemic at the time, ... enduring mysteries of classical music: What -- or who -- killed ... height of his creative powers? , Now, there,s a new theory: ... lacks the inherent drama of murder by a rival or suicide, ...
... BEDFORD, Mass., Aug. 17 Insulet Corporation (Nasdaq: ... its OmniPod(R) Insulin Management System, today announced the appointment of ... created role, Mr. Devlin will lead the Company,s Sales and ... , "Peter brings a distinguished track record ...
Cached Medicine News:Health News:Disney Donates $100,000 to Red Cross Catastrophic Disaster Planning 2Health News:Family Research Council President Tony Perkins Asks: Is This What President Obama Means by 'Robust' Conscience Protections? 2Health News:Post-treatment pain in head and neck cancer patients linked to recurrence, lower survival rate 2Health News:HeartWare International, Inc. Closes US$60 Million Financing 2Health News:HeartWare International, Inc. Closes US$60 Million Financing 3Health News:Strep Throat May Have Led to Mozart's Death 2Health News:Strep Throat May Have Led to Mozart's Death 3Health News:Insulet Appoints Peter J. Devlin as Chief Commercial Officer 2
The Fujinon's R410 laparoscope is the first to bring a 410,000 pixel CCD to the end of the scope. Superior imaging and color replication, along with a unique lens washing capability make the R410 the...
The ACMI™ Operative Laparoscopy System is designed for single- and dual-incision CO2 laser procedures and is used with 45cm laparoscopic instruments....
The edge-to-edge clarity of the laparoscopes provides excellent image definition.Even small structures are easily recognized due to the optimal depth of focus. The outstanding optical quality provide...
Stryker bariatric laparoscopes set the standard in picture quality....
Medicine Products: